173 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Attracts, retains, and incentivizes talented executives capable of leading our business in a highly complex and competitive environment 1 2 100
8-K
EX-1.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, “environmental laws
SC TO-T
EX-99
3lbq mh9cdpd2
25 Jan 24
Third party tender offer statement
8:13am
8-K
EX-99.1
dt1ku3xxeq uj5v
8 Jan 24
Regulation FD Disclosure
10:29am
8-K
EX-1.1
0mfw5q0rzt l5jxv
13 Nov 23
Other Events
4:19pm
DEFA14A
50avpt gikgnl215fbki
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.1
0kvt w3b3
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.1
wbsw4hvgv0tp1z 9bhl
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
SC TO-T
EX-99
u4196kr6 8z
17 Jun 22
Third party tender offer statement
4:42pm
8-K
EX-99.1
or6re6on
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
8-K
EX-99.3
iyo35 6k97tvu16zd
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
DEFA14A
sih1vzl
20 Apr 22
Additional proxy soliciting materials
4:30pm
8-K
EX-1.1
g1fr9s0yx 7n5fk5qa
22 Feb 22
Bristol Myers Squibb Prices $6 Billion of Senior Unsecured Notes
6:01am
8-K
EX-99.3
50ysqb31q4ui7j5j q7w
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am
8-K
EX-99.1
qohu54o
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am